Eric M McDade DO
Neurodegenerative, Dementia & Geriatrics
Professor of Neurology Washington University School of Medicine. Co-Director Dominantly Inherited Alzheimer Network Trials Unit.
Join to View Full Profile
4921 Parkview Pl# DvSaint Louis, MO 63110
Phone+1 314-362-1408
Fax+1 314-286-1985
Dr. McDade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Eric McDade is a neurologist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital. He received his medical degree from Chicago College of Osteopathic Medicine at Midwestern University and has been in practice 12 years. He specializes in neurodegenerative and dementia & geriatrics and is experienced in alzheimer's disease and aphasia. He has more than 100 publications and over 500 citings.
Education & Training
Mayo Clinic College of Medicine and ScienceFellowship, Behavioral neurology, 2008 - 2010
University of MarylandResidency, Neurology, 2005 - 2008
University of Illinois College of Medicine at ChicagoInternship, Internal Medicine, 2004 - 2005
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2004
Certifications & Licensure
IL State License 2021 - 2026
MO State License 2016 - 2026
PA State License 2010 - 2016
MN State License 2008 - 2010
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
Publications & Presentations
PubMed
- Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, ...Randall J Bateman, Yan Li, Eric M McDade, Jorge J Llibre-Guerra, David B Clifford
The Lancet. Neurology. 2025-04-01 - Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.David M Cash, Katy E Morgan, Antoinette O'Connor, Thomas D Veale, Ian B Malone
The Journal of Prevention of Alzheimer's Disease. 2025-03-20 - Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease.David M Cash, Katy E Morgan, Antoinette O'Connor, Thomas D Veale, Ian B Malone
Medrxiv. 2025-03-07
Other
- Stop Alzheimer’s Before It StartsEric McDade, DO, Nature
https://www.doximity.com/articles/ec48e4b3-4116-4a55-ab3e-a95a0da3c80b
UpToDate, Wolters Kluwer Health - 2011-10-05 - Stop Alzheimer’s Before It StartsEric McDade, DO, Nature
https://www.doximity.com/articles/ec48e4b3-4116-4a55-ab3e-a95a0da3c80b
UpToDate, Wolters Kluwer Health - 2013-02-06
Press Mentions
Small Study Hints Anti-Amyloid Therapy May Keep Alzheimer’s Symptoms at Bay in Certain PatientsMarch 21st, 2025- Groundbreaking Alzheimer’s Prevention Trial Starts for Young AdultsFebruary 4th, 2025
- International Alzheimer’s Prevention Trial in Young Adults BeginsFebruary 4th, 2025
- Join now to see all
Grant Support
- Multidisciplinary Training in Alzheimer and Related DementiasWASHINGTON UNIVERSITY2018–2029
- DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2026
- DIAN-TU Primary Prevention TrialWASHINGTON UNIVERSITY2018–2026
- K23National Institution on Aging2015–2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
